Envarsus XR 1 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F1M68
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,006
Award facts
- Contract value 100% obligated
- $15,006.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Envarsus XR 1 mg tablets (30-count packages) with a ceiling value of $15,006.20. This firm fixed-price delivery order, with an ultimate completion date of December 29, 2025, represents a non-competitive award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. No set-aside designation was applied to this award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through its comprehensive product portfolio.
This delivery order falls under AmerisourceBergen's existing Indefinite Delivery/Indefinite Quantity (IDIQ) contract valued at $999,999,999.00 and running through December 2026, which enables the company to supply pharmaceutical products and medical supplies globally to support military healthcare programs. Envarsus XR, a brand-name immunosuppressant medication, supports the Defense Health Agency's medical supply chain requirements. AmerisourceBergen's federal contract portfolio demonstrates consistent capability to deliver specialized pharmaceutical products across multiple therapeutic domains, positioning the company as a key supplier within DLA's pharmaceutical distribution network serving defense and civilian healthcare beneficiaries.
Quick answers
Who was awarded contract SPE2DR26F1M68?
SPE2DR26F1M68 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 5, 2025.
How much is contract SPE2DR26F1M68 worth?
The government has obligated $15,006 on SPE2DR26F1M68.
Is contract SPE2DR26F1M68 an order under another contract?
Yes. SPE2DR26F1M68 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1M68 competed?
The extent of competition for SPE2DR26F1M68 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award